title: How to incorporate new tyrosine kinase inhibitors in the treatment of patients with medullary thyroid cancer.
authors.affiliation: Dana-Farber Cancer Institute, Harvard Medical School; and Brigham and Women's Hospital, Boston, MA.
authors.forename: Robert I
authors.initials: RI
authors.lastname: Haddad
mesh_terms: D000813:Anilides / Q000627:therapeutic use*; D018278:Carcinoma, Neuroendocrine; D005260:Female; D006801:Humans; D008297:Male; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use*; D011725:Pyridines / Q000627:therapeutic use*; D013964:Thyroid Neoplasms / Q000188:drug therapy*
chemical_list: D000813:Anilides; D047428:Protein Kinase Inhibitors; D011725:Pyridines; C558660:cabozantinib